Remnant-like particle cholesterol (RLP-C) is atherogenic.
This study investigated the effects of icosapent ethyl on RLP-C.
Icosapent ethyl significantly reduced RLP-C in the MARINE and ANCHOR studies.
RLP-C reductions occurred in all patients, including statin-treated patients.
Strong correlations were found between calculated and directly measured RLP-C.